Sign Up Today and Learn More About LYNK Pharmaceuticals Stock
Invest in or calculate the value of your shares in LYNK Pharmaceuticals or other pre-IPO companies through EquityZen's platform.
LYNK Pharmaceuticals Stock (LYPH)
LYNK Pharmaceuticals is a biotech company focusing on the discovery and development of novel medicines.
About LYNK Pharmaceuticals Stock
Founded
2018
Industries
Science and Engineering, Health Care, Biotechnology
LYNK Pharmaceuticals Press Mentions
Stay in the know about the latest news on LYNK Pharmaceuticals
Tyk2 inhibitors and compositions and methods thereof
patents • Apr 02, 2025
Benzamides of pyrazolyl-amino-pyrimidinyl derivatives and compositions and …
patents • Apr 02, 2025
Benzethers and anilines of pyrazolyl-amino-pyrimidinyl derivatives, and …
patents • Apr 02, 2025
Tricyclic Janus kinase 1 inhibitors, and compositions and methods thereof
patents • Feb 09, 2025
Benzamides of pyrazolyl-amino- pyrimidinyl derivatives, and compositions and …
patents • Feb 09, 2025
LYNK Pharmaceuticals Management
Leadership team at LYNK Pharmaceuticals
CEO
Zhao-Kui (ZK) Wan
COO
Jardo Chein
Join now and verify your accreditation status to gain access to:
- LYNK Pharmaceuticals Current Valuation
- LYNK Pharmaceuticals Stock Price
- LYNK Pharmaceuticals Management
- Available deals in LYNK Pharmaceuticals and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- LYNK Pharmaceuticals Cap Table and Funding History by Share Class and Liquidity Preferences
- LYNK Pharmaceuticals Revenue and Financials
- LYNK Pharmaceuticals Highlights
- LYNK Pharmaceuticals Business Model
- LYNK Pharmaceuticals Risk Factors
- LYNK Pharmaceuticals Research Report from SACRA Research
Trading LYNK Pharmaceuticals Stock
How to invest in LYNK Pharmaceuticals stock?
Accredited investors can buy pre-IPO stock in companies like LYNK Pharmaceuticals through EquityZen funds. These investments are made available by existing LYNK Pharmaceuticals shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell LYNK Pharmaceuticals stock?
Shareholders can sell their LYNK Pharmaceuticals stock through EquityZen's private company marketplace. EquityZen's network includes over 380K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 47K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
